Are you getting the best rate from your broker?
Compare your broker's rates now to find out if you can save money

Choose your broker below
Welcome to ETFdb.com. Please help us personalize your experience.

Select the one that best describes you

PSCH
Invesco S&P SmallCap Health Care ETF

Price: $155.18
Change: $2.27 (0.01%)
Last Updated:

Vitals

Investment Themes

Trading Data

Open - Volume -
Day Lo - Day Hi -
  • Open
  • Volume
  • Day Lo
  • Day Hi
  • 52 Week Lo $83.54
  • 52 Week Hi $155.98
  • AUM $421.2 M
  • Shares 2.8 M

Analyst Report

This fund gives investors exposure to the small cap health care industry, a market segment that has both value and growth characteristics. Securities in this corner of the market can be also be prone to quick shifts in sentiment thanks to changing government regulations or policies. Furthermore, many companies in this corner of the market are unprofitable and rely on FDA drug approval in order to snap back into the green, a very risky proposition. With that being said, PSCH gives investors a nice mix of biotech, pharma, medical tech, and facility companies spreading risk around the various corners of the health care world. However, it should be noted that the fund does still have singificant concentrattion in its top ten holdings as these companies make up close to one third of total assets, rather high considering the fund only has 70 securities in total. As a result, investors should consider this fund only if they are looking to tactically tilt towards the sector or round out exposure to the health care segment.

Historical Trading Data

  • 1 Month Avg. Volume 11,461
  • 3 Month Avg. Volume 10,883

Alternative ETFs in the Health & Biotech Equities Category

Type Symbol Expense Ratio Assets Avg. Daily Vol YTD Return
Cheapest FHLC 0.08% $2.2 B 182,903 11.82%
Largest (AUM) XLV 0.13% $24.2 B 8 M 8.25%
Most Liquid (Volume) XLV 0.13% $24.2 B 8 M 8.25%
Top YTD Performer ARKG 0.75% $3.6 B 1 M 122.91%

Top 15 Holdings

Concentration Analysis

This section compares how balanced and deep this ETF is relative to the peer group ETFdb.com Category.

73
Number of Holdings
34.69%
% Assets in Top 10
47.40%
% Assets in Top 15
89.29%
% Assets in Top 50
Number of Holdings
73

% Assets in Top 10
34.69%

% Assets in Top 15
47.40%

% Assets in Top 50
89.29%

Sector Breakdown

Asset Percentage
Common equity 99.99%
ETF Cash Component 0.01%
Sector Percentage
Healthcare 93.06%
Other 5.55%
Technology 1.38%
ETF Cash Component 0.01%
Market Cap Percentage
Micro cap 56.62%
Small cap 43.37%
ETF Cash Component 0.01%
Region Percentage
North America 99.99%
ETF Cash Component 0.01%
Region Percentage
United States 99.99%
ETF Cash Component 0.01%
Country Percentage
United States 99.99%
ETF Cash Component 0.01%
Asset Percentage
Common equity 99.99%
ETF Cash Component 0.01%

PSCH Valuation

This section shows how the P/E multiple of this ETF compares to the peer group ETFdb.com Category.

P/E Ratio
44.71

PSCH Dividend

This section shows how the dividend yield of this ETF compares to the peer group ETFdb.com Category.

Dividend
$0.01
Dividend Date
2018-09-24
Annual Dividend Rate
n/a

$0.01
Dividend
2018-09-24
Dividend Date
n/a
Annual Dividend Rate
Annual Dividend Yield
No Ranking Available
Rank
N/A

PSCH Fund Flows

View charts featuring ETF fund flow data.

5 Day Net Flows: 0 1 Month Net Flows: -7.92 M 3 Month Net Flows: -15.27 M 6 Month Net Flows: -65.6 M 1 Year Net Flows: -102.62 M 3 Year Net Flows: 129.95 M 5 Year Net Flows: 89.6 M 10 Year Net Flows: 166.34 M

Realtime Rating

The adjacent table gives investors an individual Realtime Rating for PSCH on several different metrics, including liquidity, expenses, performance, volatility, dividend, concentration of holdings in addition to an overall rating. The "A+ Metric Rated ETF" field, available to ETFdb Pro members, shows the ETF in the Health & Biotech Equities with the highest Metric Realtime Rating for each individual field. To view all of this data, sign up for a free 14-day trial for ETFdb Pro. To view information on how the ETFdb Realtime Ratings work, click here.

Metric Metric Realtime Rating A+ Metric Rated ETF
Liquidity B- n/a
Expenses A n/a
Performance
Volatility
Dividend
Concentration

A+ Overall Rated ETF:

PSCH Expenses & Fees

This section compares the cost efficiency of this ETF to peers in the same ETFdb.com Category.

Expenses Ratio Analysis

ETF Average
0.534%
ETF Wtd. Average
-0.13%
Category Average
0.46%
Expense Ratio
0.29%
ESG Themes and Scores
4.58/10
ESG Score
25.97%
Global Percentile
23.77%
Peer Percentile
    • Revenue Exposure to Environmental Impact (%)
      Higher is better, no ESG score impact
    • Severe Environment Controversies (%)
      Lower improves ESG score
    • Sustainable Impact Solutions (%)
      12.4%
      Higher is better, no ESG score impact
    • Weighted Average Carbon Intensity (Tons of CO2e / $M Sales)
      23.43
      Higher is worse, no ESG score impact
    • Fossil Fuel Reserves (%)
      Higher is worse, no ESG score impact
    • High Impact Fossil Fuel Reserves (%)
      Higher is worse, no ESG score impact
    • Water Stress High Risk Business Segment (%)
      Lower improves ESG score
    • Water Stress High Risk Geography (%)
      Lower improves ESG score
    • Water Stress Exposure Moderate (%)
      Lower improves ESG score
    • Water Stress Exposure High (%)
      Lower improves ESG score
    • Water Stress Exposure Low (%)
      Higher improves ESG score
    • Revenue Exposure to Energy Efficiency (%)
      Higher is better, no ESG score impact
    • Revenue Exposure to Alternative Energy (%)
      Higher is better, no ESG score impact
    • Revenue Exposure to Green Building (%)
      Higher is better, no ESG score impact
    • Revenue Exposure to Pollution Prevention (%)
      Higher is better, no ESG score impact
    • Revenue Exposure to Water Sustainability (%)
      Higher is better, no ESG score impact
    • Revenue Exposure to Social Impact (%)
      Higher is better, no ESG score impact
    • Sustainable Impact Solutions (%)
      12.4%
      Higher is better, no ESG score impact
    • SRI Exclusion Criteria (%)
      0.0%
      Higher is worse, no ESG score impact
    • Revenue Exposure to Affordable Real Estate (%)
      Higher is better, no ESG score impact
    • Revenue Exposure to Education (%)
      Higher is better, no ESG score impact
    • Revenue Exposure to Major Disease Treatment (%)
      Higher is better, no ESG score impact
    • Revenue Exposure to Nutrition (%)
      Higher is better, no ESG score impact
    • Revenue Exposure to Sanitation (%)
      Higher is better, no ESG score impact
    • Revenue Exposure to SME Finance (%)
      Higher is better, no ESG score impact
    • Human Rights Norms Violation (%)
      Higher is worse, no ESG score impact
    • Human Rights Norms Violation OR Watch List (%)
      Higher is worse, no ESG score impact
    • Severe Human Rights Controversies (%)
      Lower improves ESG score
    • Labor Norms Violation (%)
      Higher is worse, no ESG score impact
    • Labor Norms Violation OR Watch List (%)
      Higher is worse, no ESG score impact
    • Severe Labor Controversies (%)
      Lower improves ESG score
    • Severe Customer Controversies (%)
      Lower improves ESG score
    • Global Compact Compliance Violation (%)
      Higher is worse, no ESG score impact
    • Global Compact Compliance Violation OR Watch List (%)
      Higher is worse, no ESG score impact
    • Catholic Values Fail (%)
      Higher is worse, no ESG score impact
    • Islamic Non-Compliant (%)
      Higher is worse, no ESG score impact
    • Adult Entertainment Involvement (%)
      Higher is worse, no ESG score impact
    • Alcohol Involvement (%)
      Higher is worse, no ESG score impact
    • Gambling Involvement (%)
      Higher is worse, no ESG score impact
    • Nuclear Power Involvement (%)
      Higher is worse, no ESG score impact
    • Tobacco Involvement (%)
      Higher is worse, no ESG score impact
    • Weapons Involvement (%)
      Higher is worse, no ESG score impact
    • Controversies Weapons Involvement (%)
      Higher is worse, no ESG score impact
    • Civilian Firearms Involvement (%)
      Higher is worse, no ESG score impact
    • Civilian Firearms Retailer (%)
      Higher is worse, no ESG score impact
    • Civilian Firearms Producer (%)
      Higher is worse, no ESG score impact
    • Direct Predatory Lending Involvement (%)
      Higher is worse, no ESG score impact
    • Genetic Engineering Involvement (%)
      Higher is worse, no ESG score impact
    • Severe Governance Controversies (%)
      Lower improves ESG score
    • Board Flag (%)
      Lower improves ESG score
    • Lack of Independent Board Majority (%)
      Lower improves ESG score
    • Board Independence (0-25%) (%)
      Lower improves ESG score
    • Board Independence (25-50%) (%)
      Lower improves ESG score
    • Board Independence (50-75%) (%)
      Higher improves ESG score
    • Board Independence (75-100%) (%)
      Higher improves ESG score
    • No Female Directors (%)
      Lower improves ESG score
    • Three OR More Female Directors (%)
      Higher improves ESG score
    • Females Represent 30% of Directors (%)
      Higher improves ESG score
    • Entrenched Board (%)
      Lower improves ESG score
    • Overboarding (%)
      Lower improves ESG score
    • Negative Director Votes (%)
      Lower improves ESG score
    • Ownership AND Control Flag (%)
      Lower improves ESG score
    • One Share One Vote (%)
      Lower improves ESG score
    • No Annual Director Elections (%)
      Lower improves ESG score
    • Does Not Use Majority Voting (%)
      Lower improves ESG score
    • Significant Votes Against Pay Practices (%)
      Lower improves ESG score
    • Controlling Shareholder (%)
      Lower improves ESG score
    • Controlling Shareholder Concerns (%)
      Lower improves ESG score
    • Cross Shareholdings (%)
      Lower improves ESG score
    • Poison Pill (%)
      Lower improves ESG score
    • Pay Flag (%)
      Lower improves ESG score
    • No Pay Performance Link (%)
      Lower improves ESG score
    • Lack of Internal Pay Equity (%)
      Lower improves ESG score
    • Executive Pay Non-Disclosure (%)
      Lower improves ESG score
    • Accounting Flag (%)
      Lower improves ESG score

PSCH Performance

This section shows how this ETF has performed relative to its peer group ETFdb.com Category.

2.70%
1 Week Return
12.95%
4 Week Return
16.93%
13 Week Return
28.61%
26 Week Return
20.09%
Year to Date Return
21.22%
1 Year Return
60.68%
3 Year Return
119.14%
5 Year Return
1 Week Return
2.70%

4 Week Return
12.95%

13 Week Return
16.93%

26 Week Return
28.61%

Year to Date Return
20.09%

1 Year Return
21.22%

3 Year Return
60.68%

5 Year Return
119.14%

PSCH Price and Volume Chart

PSCH Technicals

Volatility Analysis

This section shows how the volatility of this ETF compares to the peer group ETFdb.com Category.

5 Day Volatility
108.58%
Rank
12 of 40

20 Day Volatility
25.00%
Rank
22 of 40

50 Day Volatility
22.93%
Rank
20 of 40

200 Day Volatility
23.18%
Rank
15 of 38

Beta
1.14
Rank
9 of 40

Standard Deviation
12.47%
Rank
10 of 36

Technicals

  • 20 Day MA $144.76
  • 60 Day MA $137.10
  • MACD 15 Period 7.42
  • MACD 100 Period 21.58
  • Williams % Range 10 Day 7.35
  • Williams % Range 20 Day 3.39
  • RSI 10 Day 75
  • RSI 20 Day 69
  • RSI 30 Day 66
  • Ultimate Oscillator 64

Bollinger Brands

  • Lower Bollinger (10 Day) $145.34
  • Upper Bollinger (10 Day) $154.58
  • Lower Bollinger (20 Day) $131.88
  • Upper Bollinger (20 Day) $157.44
  • Lower Bollinger (30 Day) $130.74
  • Upper Bollinger (30 Day) $154.58

Support & Resistance

  • Support Level 1 $153.85
  • Support Level 2 $152.53
  • Resistance Level 1 $156.24
  • Resistance Level 2 $157.30

Stochastic

  • Stochastic Oscillator %D (1 Day) 66.51
  • Stochastic Oscillator %D (5 Day) 81.57
  • Stochastic Oscillator %K (1 Day) 62.12
  • Stochastic Oscillator %K (5 Day) 76.68

Fact Sheet

Fact sheets are issued by the ETF provider and framed by ETFdb.com. Information contained within the fact sheet is not guaranteed to be timely or accurate.

Disclosures

Copyright © 2020 FactSet Research Systems Inc. All rights reserved.

Copyright MSCI ESG Research LLC [2018]. All Rights Reserved. MSCI ESG Research LLC’s (“MSCI ESG”) Fund Metrics products (the “Information”) provide environmental, social and governance data with respect to underlying securities within more than 23,000 multi-asset class Mutual Funds and ETFs globally. MSCI ESG is a Registered Investment Adviser under the Investment Advisers Act of 1940. MSCI ESG materials have not been submitted, to nor received approval from, the US SEC or any other regulatory body. None of the information constitutes an offer to buy or sell, or a promotion or recommendation of, any security, financial instrument or product or trading strategy, nor should it be taken as an indication or guarantee of any future performance, analysis, forecast or prediction. None of the Information can be used to determine which securities to buy or sell or when to buy or sell them. The Information is provided “as is” and the user of the Information assumes the entire risk of any use it may make or permit to be made of the Information. All Information is provided solely for your internal use, and may not be reproduced or redisseminated in any form without express prior written permission from MSCI. Neither MSCI ESG nor any of its affiliates or any third party involved in or related to creating any Information makes any express or implied warranties, representations or guarantees, and in no event will MSCI ESG or any such affiliate or third party have any liability for any direct, indirect, special, punitive, consequential or any other damages (including lost profits) relating to any Information. More information on MSCI ESG Fund Metrics, provided by MSCI ESG Research LLC, can be found at https://www.msci.com/esg-fund-metrics.
© 2020 Market data provided is at least 15-minutes delayed and hosted by Barchart Solutions.

Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use, please see disclaimer.